FDA Modernization Act 3.0
Sponsored by Earl L. "Buddy" Carter RRepublican, introduced . Policy area, as Congress files it: Health.
Status is read from the official actions by their Library of Congress codes: Became Public Law (36000) or a law number on the bill reads "Became law"; Vetoed (31000) reads "Vetoed"; Presented to President (28000) reads "Sent to the President"; passed or agreed to in the House (8000) and in the Senate (17000) reads "Passed both chambers"; one of them alone reads "Passed the House" or "Passed the Senate" ("Agreed to" for a resolution); reported to the House (5000) or the Senate (14000) reads "Reported by committee"; anything else reads "Introduced".
Source: Congress.gov data service (Library of Congress). Text versions: our copies of govinfo.gov’s files. Our copy was saved October 14, 2026.
Cosponsors
41 cosponsors.
Text
| Version | Date | Our copy |
|---|---|---|
| Engrossed in House | Read our copyThe official file | |
| Reported in House | Read our copyThe official file | |
| Introduced in House | Read our copyThe official file |
Actions
- Received in the Senate.
- Motion to reconsider laid on the table Agreed to without objection.
- On motion to suspend the rules and pass the bill Agreed to by voice vote. (text: CR H4639)
- Passed/agreed to in House: On motion to suspend the rules and pass the bill Agreed to by voice vote. (text: CR H4639)
- DEBATE - The House proceeded with forty minutes of debate on H.R. 2821.
- Considered under suspension of the rules. (consideration: CR H4639-4640)
- Mr. Guthrie moved to suspend the rules and pass the bill.
- Placed on the Union Calendar, Calendar No. 614.
- Reported by the Committee on Energy and Commerce. H. Rept. 119-706.
- Reported by the Committee on Energy and Commerce. H. Rept. 119-706.
- Ordered to be Reported by the Yeas and Nays: 44 - 0.
- Committee Consideration and Mark-up Session Held
- Forwarded by Subcommittee to Full Committee by Voice Vote.
- Subcommittee Consideration and Mark-up Session Held
- Referred to the Subcommittee on Health.
- Referred to the House Committee on Energy and Commerce.
- Introduced in House
- Introduced in House
Committees
- Energy and Commerce Committee (House)Reported By, June 18, 2026; Markup By, May 21, 2026; Referred To, April 10, 2025
Hearings
We hold hearing records only for bills that became law.
Who lobbied on this bill
Confirmed from the official record1 lobbying report name H.R. 2821, for 1 client.
| Client | Registrant | Amount for the whole quarter | Lobbyists named for this issue | Filed | Report |
|---|---|---|---|---|---|
| CONSUMER HEALTHCARE PRODUCTS ASSOCIATION | CONSUMER HEALTHCARE PRODUCTS ASSOCIATIONSecond quarter of 2026 | $199,750reported as income |
| Open the report |
A lobbying report states the registrant's income from the client (a lobbying firm) or its own lobbying expenses (an organization lobbying for itself), for the whole quarter and every issue together, rounded to the nearest $10,000. A report under $5,000 states no figure. It is not the amount spent on one bill.
Reports read: 0 of 1 quarters read in full (2026-Q2). With no registered key the service allows 15 requests a minute, so this covers the latest quarter only. With a key it covers four.
Senate Office of Public Records cannot vouch for the data or analyses derived from these data after the data have been retrieved from LDA.gov.
All saved lobbying reports that name H.R. 2821
Contributions from these lobbyists and firms to the sponsor and cosponsors
No contribution report we hold ties a lobbyist or firm on these reports to the sponsor or a cosponsor.
Contribution reports are read for 6 of the 42 sponsors and cosponsors so far.
Lobbyists and registrants report their political contributions twice a year (form LD-203). A contribution is listed here when the report was filed by a lobbyist named on this bill's lobbying reports or by a registrant that filed one of them, and its payee is the member's own committee as the FEC lists it, under the exact-name rule. The contribution's date is as reported and can fall before or after the lobbying.